Get the Stockscreener App
73.24
4.85%
3.39
Pre-market:
72.41
-0.83
-1.13%
Vaxcyte Inc Stock (PCVX) Forecast
The Vaxcyte Inc (PCVX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $68.75, representing a -6.13% decrease from the current price of $73.24. The highest analyst price target is $71.24, and the lowest is $66.26.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PCVX Price Target
Average 75.43
(+2.99% Upside)
Is Vaxcyte Inc (PCVX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.12 | Neutral |
| STOCH(9,6) | 29.15 | Neutral |
| STOCHRSI(14) | 94.73 | Sell |
| MACD(12,26) | -3.9096 | Sell |
| ADX(14) | 31.93 | Sell |
| William %R | -64.17 | Neutral |
| CCI(14) | -21.93 | Neutral |
Buy: 0
Sell: 3
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
72.14
Buy
|
73.14
Buy
|
| MA20 |
77.12
Sell
|
76.26
Sell
|
| MA50 |
82.54
Sell
|
81.84
Sell
|
| MA100 |
89.98
Sell
|
85.97
Sell
|
| MA200 |
89.09
Sell
|
84.80
Sell
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, PCVX could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on PCVX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.12 indicates that PCVX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 29.15 indicates that PCVX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 94.73 indicates that PCVX is oversold. This suggests that PCVX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 31.93 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -21.93 indicates that PCVX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term PCVX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Vaxcyte Inc financial reports and earnings history, Vaxcyte Inc (PCVX) stock could reach $134.32 by 2030, $295.49 by 2040 and $537.30 by 2050. See the projected annual prices until 2050 of the Vaxcyte Inc stock below:
- Vaxcyte Inc (PCVX) is expected to reach an average price of $201.72 in 2035, with a high prediction of $202.57 and a low estimate of $195.32. This indicates an $175.43% rise from the last recorded price of $73.24.
- Vaxcyte Inc (PCVX) stock is projected to chart a bullish course in 2040, with an average price target of $295.24, representing an $303.11% surge from its current level. The forecast ranges from a conservative $288.83 to a sky-high $295.49.
- Our analysts predict Vaxcyte Inc (PCVX) to jump 466.47% by 2045, soaring from $411.28 to an average price of $414.88, potentially reaching $417.29. While $411.28 is the low estimate, the potential upside is significant.
- Vaxcyte Inc (PCVX) stock is expected to climb by 2050, reaching an average of $537.22, a $633.50% jump from its current level. However, a wide range of estimates exists, with high and low targets of $537.30 and $529.84, respectively, highlighting the market's uncertainty.
Vaxcyte Inc Stock (PCVX) Year by Year Forecast
Vaxcyte Inc Stock (PCVX) Price Forecast for 2025
Vaxcyte Inc Stock (PCVX) is expected to reach an average price of $74.35 in 2025, with a high prediction of $83.25 and a low estimate of $65.45. This indicates an +1.52% rise from the last recorded price of $73.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $68.04 | $66.26 | $71.24 | -7.10% |
| May, 2025 | $71.47 | $65.45 | $72.89 | -2.41% |
| June, 2025 | $75.34 | $71.03 | $75.91 | +2.87% |
| July, 2025 | $75.03 | $72.22 | $76.42 | +2.44% |
| August, 2025 | $74.87 | $72.96 | $80.88 | +2.23% |
| September, 2025 | $80.54 | $75.27 | $81.41 | +9.96% |
| October, 2025 | $79.68 | $78.97 | $81.82 | +8.80% |
| November, 2025 | $81.79 | $77.87 | $82.16 | +11.67% |
| December, 2025 | $76.96 | $76.65 | $83.25 | +5.09% |
Vaxcyte Inc Stock (PCVX) Price Forecast for 2026
The predicted value for Vaxcyte Inc (PCVX) in 2026 is set at an average of $87.31. Estimates vary from a peak of $98.35 to a trough of $76.27, indicating an +19.21% surge from the present price of $73.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $82.37 | $76.78 | $84.17 | +12.46% |
| February, 2026 | $77.34 | $76.27 | $85.41 | +5.60% |
| March, 2026 | $80.83 | $77.47 | $81.68 | +10.36% |
| April, 2026 | $87.61 | $79.22 | $88.16 | +19.63% |
| May, 2026 | $88.21 | $84.93 | $89.30 | +20.44% |
| June, 2026 | $87.75 | $85.58 | $89.93 | +19.82% |
| July, 2026 | $86.55 | $84.51 | $90.87 | +18.17% |
| August, 2026 | $87.35 | $82.56 | $87.44 | +19.26% |
| September, 2026 | $89.83 | $86.95 | $91.99 | +22.66% |
| October, 2026 | $95.49 | $89.38 | $95.69 | +30.38% |
| November, 2026 | $94.75 | $93.26 | $98.35 | +29.37% |
| December, 2026 | $90.37 | $90.28 | $96.15 | +23.39% |
Vaxcyte Inc Stock (PCVX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Vaxcyte Inc (PCVX) is $119.21, with a high forecast of $135.41 and a low forecast of $103.01. This indicates an +62.77% increase from the last price of $73.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $115.14 | $103.01 | $117.29 | +57.21% |
| February, 2027 | $116.57 | $111.06 | $119.09 | +59.16% |
| March, 2027 | $119.48 | $113.03 | $122.14 | +63.13% |
| April, 2027 | $119.11 | $113.57 | $121.21 | +62.63% |
| May, 2027 | $116.39 | $116.18 | $120.57 | +58.92% |
| June, 2027 | $113.70 | $112.22 | $118.39 | +55.24% |
| July, 2027 | $121.92 | $110.67 | $123.89 | +66.46% |
| August, 2027 | $125.96 | $118.60 | $132.33 | +71.98% |
| September, 2027 | $130.05 | $125.97 | $132.54 | +77.56% |
| October, 2027 | $129.47 | $125.62 | $134.10 | +76.78% |
| November, 2027 | $130.43 | $126.07 | $131.64 | +78.08% |
| December, 2027 | $135.03 | $126.73 | $135.41 | +84.37% |
Vaxcyte Inc Stock (PCVX) Price Forecast for 2028
In 2028, Vaxcyte Inc (PCVX) is projected to reach an average price of $131.83, with a high projection of $170.75 and a low estimate of $92.92. This indicates an +80.00% rise from the last price of $73.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $133.85 | $129.77 | $136.35 | +82.75% |
| February, 2028 | $130.80 | $127.53 | $135.02 | +78.59% |
| March, 2028 | $134.30 | $130.81 | $137.10 | +83.37% |
| April, 2028 | $146.46 | $133.55 | $147.96 | +99.98% |
| May, 2028 | $147.64 | $140.43 | $152.57 | +101.59% |
| June, 2028 | $162.82 | $148.31 | $164.73 | +122.30% |
| July, 2028 | $160.65 | $160.49 | $170.75 | +119.35% |
| August, 2028 | $154.10 | $152.11 | $163.36 | +110.40% |
| September, 2028 | $151.59 | $148.91 | $155.62 | +106.98% |
| October, 2028 | $108.94 | $92.92 | $155.51 | +48.75% |
| November, 2028 | $109.21 | $103.03 | $112.59 | +49.11% |
| December, 2028 | $131.65 | $106.97 | $135.30 | +79.75% |
Vaxcyte Inc Stock (PCVX) Price Forecast for 2029
The 2029 price forecast for Vaxcyte Inc Stock (PCVX) is $127.93 on average, with a high prediction of $141.54 and a low estimate of $114.33. This represents an +74.67% increase from the previous price of $73.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $133.06 | $117.38 | $134.74 | +81.68% |
| February, 2029 | $133.06 | $129.28 | $141.54 | +81.68% |
| March, 2029 | $122.31 | $121.48 | $137.67 | +67.00% |
| April, 2029 | $120.27 | $119.32 | $125.91 | +64.21% |
| May, 2029 | $117.18 | $115.32 | $124.28 | +60.00% |
| June, 2029 | $116.93 | $115.19 | $121.88 | +59.66% |
| July, 2029 | $117.83 | $116.68 | $122.63 | +60.88% |
| August, 2029 | $116.36 | $114.33 | $123.97 | +58.87% |
| September, 2029 | $117.44 | $115.49 | $120.01 | +60.36% |
| October, 2029 | $121.88 | $115.39 | $123.30 | +66.41% |
| November, 2029 | $126.68 | $121.67 | $127.25 | +72.96% |
| December, 2029 | $126.05 | $124.50 | $128.00 | +72.10% |
Vaxcyte Inc Stock (PCVX) Price Forecast for 2030
Vaxcyte Inc Stock (PCVX) is expected to reach an average price of $140.57 in 2030, with a high forecast of $155.09 and a low forecast of $126.04. This signifies an +91.93% surge from the last price of $73.24.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $128.31 | $126.04 | $134.32 | +75.19% |
| February, 2030 | $134.91 | $128.95 | $135.79 | +84.20% |
| March, 2030 | $136.85 | $134.36 | $136.98 | +86.85% |
| April, 2030 | $135.88 | $134.03 | $137.22 | +85.52% |
| May, 2030 | $135.20 | $134.02 | $140.20 | +84.60% |
| June, 2030 | $140.85 | $134.41 | $140.95 | +92.31% |
| July, 2030 | $136.86 | $135.55 | $144.22 | +86.86% |
| August, 2030 | $141.27 | $137.22 | $142.12 | +92.89% |
| September, 2030 | $147.05 | $139.90 | $148.57 | +100.78% |
| October, 2030 | $150.76 | $146.79 | $151.85 | +105.84% |
| November, 2030 | $151.24 | $148.59 | $153.42 | +106.49% |
| December, 2030 | $152.82 | $148.22 | $155.09 | +108.66% |
3.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):